Can abatacept induce immunological remission under tight control in rheumatoid arthritis patient?
Phase 4
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000005570
- Lead Sponsor
- Department of Rheumatosurgery, Osaka City University Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with leukocyte less than 4000/mm3, lymphocytes 1000/mm3, ADL activity in class IV, interstitial pneumonia, active hepatitis B, active tuberculosis, compromised condition, malignant tumor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in values of anti-cyclic citrullinated peptide antibody, rheumatoid factor, IgG that lack galactose, and type IgG rheumatoid factor
- Secondary Outcome Measures
Name Time Method Scores in joint echo for hand and wrist